Natural killer (NK) activity was determined in 20 patients ranging in age from 30 to 79 years (mean 59.9). There were six cases ofacquired idiopathic sideroblastic anemia (AISA), nine cases of refractory anemia (RA), four cases of refractory anemia with an excess of blasts (RAEB), and one case of refractory anemia with an excess of blasts in transformation (RAEBt). The patients were 
C. Effector Cells
Effector cells were obtained by sedimentation of heparinized blood on "Lymphoprep". Mononuclear cells were washed and resuspended in MEM supplemented with 10% FCS.
D. Target Cells
Cells of the K562 line derived from a patient with blast crisis in CML were used as targets [7] . K562 cells were cultured in RPMI 1640 medium containing 10% FCS, gentamicin and L-glutamine, under standard conditions.
E. Cytotoxicity Assay
NK activity of mononuclear cells was measured in a 4-h cytotoxicity test with 51Cr_Ia_ beled K562 cells as targets [16] . After 4-h incubation of effector cells together with targets in a 20: 1 ratio, cells were centrifuged and supernatants were collected for determination of released 51Cr in a gamma scintillation counter.
The percentage of cytolysis was calculated according to the formula:
Maximal cpm was obtained by the incubation of target cells in the presence of 1 % Triton X-100; spontaneous cpm was obtained by the incubation of target cells in MEM containing 10% FCS.
The results revealed strong suppression of NK activity in all of the preleukemic patients (11.5% ± 10.1 %) and in each of the diagnosed syndromes, as compared with the control group (30.6% ± 11.5%; Table 2 and Fig. 1) . The difference was statistically significant (P<0.01) in the Wilcoxon-Mann-Whitney test. Similar changes in NK activity in preleukemia have been detected by others [12, 19] . There are reports that suppression of NK activity was not connected with dilution of effector cells by blasts or by a reduced frequency of LGL in mononuclear cells of examined patients. Takagi and co-workers suggested that suppression ofNK activity in preleukemic patients was caused by the impaired IFN-linked regulatory system of NKC [19] .
In this study, two of the 20 investigated patients developed leukemia 2-3 months after diagnosis. Both cases showed very low NK activity: 
